SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-20-284827
Filing Date
2020-11-03
Accepted
2020-11-03 16:59:59
Documents
1
Group Members
GANASH LOKANATHENGARY LEATTHUBERT BIRNERJENS HOELLERMANNLUC MARENGEREMONICA MOSCHRESHENTHA BEEBYSTEFAN FISCHERTVM LIFE SCIENCE INNOVATION I (GP) LTDTVM LIFE SCIENCE INNOVATION II (GP) S.A R.L.TVM LIFE SCIENCE INNOVATION II SCSP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d48498dsc13da.htm SC 13D/A 187605
  Complete submission text file 0001193125-20-284827.txt   189600
Mailing Address AM STRANDE 7 ROSTOCK 2M 18055
Business Address AM STRANDE 7 ROSTOCK 2M 18055 49 30 2130 00325
Centogene N.V. (Subject) CIK: 0001757097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91220 | Film No.: 201284228
SIC: 8071 Services-Medical Laboratories

Mailing Address 204, RUE NOTRE-DAME OUEST BUREAU 350 MONTREAL Z4 H2Y 1T3
Business Address 204, RUE NOTRE-DAME OUEST BUREAU 350 MONTREAL Z4 H2Y 1T3 49 (89) 99 89 92 74
TVM Life Science Innovation I L.P. (Filed by) CIK: 0001799643 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13D/A